ABSTRACT SUBMISSION FOR ORAL PRESENTATION CLOSED AT APRIL 13, 2018
LATE BREAKING ABSTRACT FOR POSTER PRESENTATION: DEADLINE CHANGED TO APRIL 13
Lecturers and Invited Speakers: APRIL 13, 2018
Submitted abstracts will be analyzed by an Evaluation Committee appointed by the Organization Committee. Abstracts will be evaluated regarding their scientific quality and insertion in the field of purinergic signaling. Those not meeting these criteria or not being in agreement with the format mentioned below, will be rejected
Preparation of abstracts:
The abstracts must contain objectives / background, methods, results and conclusions. Inclusion of quantitative data and the number of experiments (mean values ± S.D. or S.E.) as well as details of appropriate control experiments is recommended to enable the readers to understand and judge the presented work. Distribution of the results from the same work, into various abstracts will not be accepted. The evaluation process will be rigorous to ensure that only the submissions of the highest quality will be presented, given that a limited number of slots are available.
- Abstracts must be submitted in English;
- Arial 12;
- For symbols use HTML or insert symbol;
- Maximum of 3000 characters (including spaces);
- Only the first letter of the title should be capitalised, followed by names of authors, institution, university, state and country, in which the work was performed.
In order to ensure that your name will be cited uniformly, make sure that your name is always written in the same way in all abstracts where you are the principle or a co-author. Names of authors and their institutional affiliation should be cited as in the following example:
1Miazaki, H.M., 2Martins, J.R.A., 1Departamento de Execução, 2Departamento de Empreendimentos, Universidade de São Paulo, São Paulo/SP, Brazil.
Objectives / background: The scientific background and resulting objectives need to be detailed. In regards to referencing published works, follow the example: Miller et al. Proc. Natl. Acad. Sci USA 82; 2049, 2008.
Methods and results: This section should contain a brief report of employed methods and obtained results. Please, do not forget to report your measurements with units. Report mean values ± S.D. or S.E., sample size and statistical significance wherever appropriate. In regards to studies involving humans or human tissue, approval of the procedures by the ethics committee of the university needs to be stated.
Conclusion: The abstract needs to be finalized with a conclusion.
Acknowledgment of financial support should be presented in the last line of the abstract.
- Abstracts exceeding the limit of characters or submitted in a different format from the indicated one will be automatically rejected by the system.
- Citations: Please, refer to the example above. Citation such as Ashley et al., 1994, with no details of the journal will not be accepted.
- Abstract containing various spelling and grammatical errors will be rejected.
- In regards to studies on human beings, in addition to attaching an obligatory copy of the ethics approval, please, state also the patients age and gender.
- In regards to the use of laboratory animals, the strains, ages / weights and gender need to be identified. If judged necessary, the evaluation committee can request a copy of the respective ethics committee of the institution.
- The data presented in the poster must be substantially similar to those described in the abstract. Particularly, title and authors must match those of the approved abstract.